Cargando…

Porphyrin Derivative Nanoformulations for Therapy and Antiparasitic Agents

Porphyrins and analogous macrocycles exhibit interesting photochemical, catalytic, and luminescence properties demonstrating high potential in the treatment of several diseases. Among them can be highlighted the possibility of application in photodynamic therapy and antimicrobial/antiparasitic PDT,...

Descripción completa

Detalles Bibliográficos
Autores principales: Deda, Daiana K., Iglesias, Bernardo A., Alves, Eduardo, Araki, Koiti, Garcia, Celia R. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249045/
https://www.ncbi.nlm.nih.gov/pubmed/32365664
http://dx.doi.org/10.3390/molecules25092080
_version_ 1783538512513990656
author Deda, Daiana K.
Iglesias, Bernardo A.
Alves, Eduardo
Araki, Koiti
Garcia, Celia R. S.
author_facet Deda, Daiana K.
Iglesias, Bernardo A.
Alves, Eduardo
Araki, Koiti
Garcia, Celia R. S.
author_sort Deda, Daiana K.
collection PubMed
description Porphyrins and analogous macrocycles exhibit interesting photochemical, catalytic, and luminescence properties demonstrating high potential in the treatment of several diseases. Among them can be highlighted the possibility of application in photodynamic therapy and antimicrobial/antiparasitic PDT, for example, of malaria parasite. However, the low efficiency generally associated with their low solubility in water and bioavailability have precluded biomedical applications. Nanotechnology can provide efficient strategies to enhance bioavailability and incorporate targeted delivery properties to conventional pharmaceuticals, enhancing the effectiveness and reducing the toxicity, thus improving the adhesion to the treatment. In this way, those limitations can be overcome by using two main strategies: (1) Incorporation of hydrophilic substituents into the macrocycle ring while controlling the interaction with biological systems and (2) by including them in nanocarriers and delivery nanosystems. This review will focus on antiparasitic drugs based on porphyrin derivatives developed according to these two strategies, considering their vast and increasing applications befitting the multiple roles of these compounds in nature.
format Online
Article
Text
id pubmed-7249045
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72490452020-06-10 Porphyrin Derivative Nanoformulations for Therapy and Antiparasitic Agents Deda, Daiana K. Iglesias, Bernardo A. Alves, Eduardo Araki, Koiti Garcia, Celia R. S. Molecules Review Porphyrins and analogous macrocycles exhibit interesting photochemical, catalytic, and luminescence properties demonstrating high potential in the treatment of several diseases. Among them can be highlighted the possibility of application in photodynamic therapy and antimicrobial/antiparasitic PDT, for example, of malaria parasite. However, the low efficiency generally associated with their low solubility in water and bioavailability have precluded biomedical applications. Nanotechnology can provide efficient strategies to enhance bioavailability and incorporate targeted delivery properties to conventional pharmaceuticals, enhancing the effectiveness and reducing the toxicity, thus improving the adhesion to the treatment. In this way, those limitations can be overcome by using two main strategies: (1) Incorporation of hydrophilic substituents into the macrocycle ring while controlling the interaction with biological systems and (2) by including them in nanocarriers and delivery nanosystems. This review will focus on antiparasitic drugs based on porphyrin derivatives developed according to these two strategies, considering their vast and increasing applications befitting the multiple roles of these compounds in nature. MDPI 2020-04-29 /pmc/articles/PMC7249045/ /pubmed/32365664 http://dx.doi.org/10.3390/molecules25092080 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Deda, Daiana K.
Iglesias, Bernardo A.
Alves, Eduardo
Araki, Koiti
Garcia, Celia R. S.
Porphyrin Derivative Nanoformulations for Therapy and Antiparasitic Agents
title Porphyrin Derivative Nanoformulations for Therapy and Antiparasitic Agents
title_full Porphyrin Derivative Nanoformulations for Therapy and Antiparasitic Agents
title_fullStr Porphyrin Derivative Nanoformulations for Therapy and Antiparasitic Agents
title_full_unstemmed Porphyrin Derivative Nanoformulations for Therapy and Antiparasitic Agents
title_short Porphyrin Derivative Nanoformulations for Therapy and Antiparasitic Agents
title_sort porphyrin derivative nanoformulations for therapy and antiparasitic agents
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249045/
https://www.ncbi.nlm.nih.gov/pubmed/32365664
http://dx.doi.org/10.3390/molecules25092080
work_keys_str_mv AT dedadaianak porphyrinderivativenanoformulationsfortherapyandantiparasiticagents
AT iglesiasbernardoa porphyrinderivativenanoformulationsfortherapyandantiparasiticagents
AT alveseduardo porphyrinderivativenanoformulationsfortherapyandantiparasiticagents
AT arakikoiti porphyrinderivativenanoformulationsfortherapyandantiparasiticagents
AT garciaceliars porphyrinderivativenanoformulationsfortherapyandantiparasiticagents